Parkwalk News

13 December 2017

Microsaic Systems – signs new phase of research agreement with a global partner in biopharma

By |December 13th, 2017|

Microsaic Systems plc
(“Microsaic” or the “Company”)
Microsaic signs new phase of research agreement with a global partner in biopharma
Microsaic Systems plc (AIM: MSYS), the developer of chip-based mass spectrometry instruments, announces that it has signed a research agreement extending its collaboration with a long standing global partner in the scale up and manufacture of biopharmaceutical […]

Xeros: Proposed £25m Placing

By |December 12th, 2017|

Xeros Technology Group plc
Proposed Placing to raise approximately £25 million
Xeros Technology Group plc (AIM: XSG, ‘the Group’, ‘Xeros’), the developer and provider of patented polymer based technologies with multiple commercial applications, intends to raise approximately £25 million before fees and expenses by a Placing of 11,111,112 new ordinary shares with existing and new institutional investors […]

Portfolio company Mirriad announces £26.2m fundraising and proposed admission to AIM

By |December 8th, 2017|

Parkwalk is pleased to note that portfolio company Mirriad Advertising plc (“Mirriad”), the global video technology company and developer of native in-video advertising, has successfully priced its Initial Public Offering and has applied for the admission of its entire issued and to be issued share capital to AIM.

Mirriad has announced the raising of £26.2 […]

28 November 2017

Parkwalk closes Opsydia investment

By |November 28th, 2017|

We are delighted to announce that the Parkwalk Opportunities Fund has made an investment in Opsydia, a spin-out company from the Department of Engineering Science at the University of Oxford, specialising in designing bespoke optical systems and laser fabrication processes for complex and unique ideas.

Perpetuum – Parkwalk closes follow on investment

By |November 21st, 2017|

We have recently closed a follow-on investment in Perpetuum for the Opportunities EIS Fund, alongside existing investors IP Group and ETF.

Perpetuum is a world-leader in vibration harvester-powered wireless sensing systems used to provide information to improve the efficiency, safety and quality of railway operations.

Perpetuum’s technology provides self-powered wireless conditioning monitoring solutions for rail applications and perpetual power for […]

Parkwalk – First Light Fusion Successful Exit

By |November 20th, 2017|

Parkwalk, the leading EIS investor in UK University spin-out companies, is pleased to announce the exit of the majority of its holding in First Light Fusion via a successful sale to Oxford Sciences Innovation.

Parkwalk was one of the initial investors in the company when it was formed in June 2011 and has invested in […]

Parkwalk closes Quantum Motion Technologies investment

By |November 15th, 2017|

We are delighted to announce that the Parkwalk Opportunities Fund has made an investment in Quantum Motion Technologies, a spin-out company from scientists at University of Oxford and UCL, as part of a Seed investment round of equity funding. The company aims to develop quantum computer architectures based on silicon technology, leveraging CMOS processing […]

Animal Dynamics – Parkwalk closes follow-on investment

By |November 12th, 2017|

We are pleased to have participated in a follow-on financing round in Animal Dynamics Limited, who are developing a portfolio of products derived from research into evolutionary adaptations in flight, swimming, walking, and stealth, where nature has arrived at significant performance optimisations which can be applied to commercial products.

Parkwalk and UCEF III close NeoPhore investment

By |November 6th, 2017|

We are pleased to announce that the University of Cambridge Enterprise Fund III, managed by Parkwalk, and Parkwalk funds have made an investment in NeoPhore, a PhoreMost Ltd spinout, alongside the Cancer Research Technology Pioneer Fund and the University of Cambridge. NeoPhore’s mission is to develop novel small molecule therapies to treat cancer by […]

Parkwalk closes Arvia investment

By |November 3rd, 2017|

We are delighted to announce that Parkwalk has made a follow-on investment into Arvia Technology from the Opportunities EIS Fund.

Arvia is exploiting a disruptive new technology for the treatment of organic and microbial wastes in water.  Spun-out from the University of Manchester, Arvia has received a plethora of major sustainability and technology innovation awards over the last five […]

Parkwalk and UOIF III close MoA investment

By |November 2nd, 2017|

We are pleased to announce that the University of Oxford Innovation Fund III, managed by Parkwalk, and the Parkwalk Opportunities EIS Fund have made an investment in MoA Technology, a spin-out from the University of Oxford. The company is developing novel technology with applications in plant protection products.

16 October 2017

Paragraf – Parkwalk and UCEF V investment

By |October 16th, 2017|

We are delighted to announce that the University of Cambridge Enterprise Fund V and the Parkwalk Opportunities Fund have invested in £2.64m seed financing round in Paragraf, a spin-out from the University of Cambridge.

Paragraf is aiming to deliver the speculated capabilities of graphene and other two-dimensional materials to the real world.

Building on fundamental science […]

MedaPhor – Parkwalk investment

By |October 13th, 2017|

We are delighted to announce that the Parkwalk Opportunities Fund has  participated in the recent financing round of Medaphor Group plc, the Cardiff University Spin-out and global provider of advanced ultrasound training simulators for medical professionals.

13 September 2017

PsyOmics – follow-on investment

By |September 13th, 2017|

We are delighted to announce that the University of Cambridge Enterprise Fund V and the Parkwalk Opportunities Fund have invested in a follow-on financing round in PsyOmics, a spin-out from the Department of Chemical Engineering and Biotechnology.

The company aims to utilise blood-based diagnostics to increase the speed of diagnosis and to reduce misdiagnosis for […]

Oxford Quantum Circuits – Parkwalk investment

By |September 8th, 2017|

We are delighted to announce that the Parkwalk Opportunities Fund has completed an investment in Oxford Quantum Circuits Limited. The company was founded by Professor Peter Leek, who is based at the Clarendon Laboratory Oxford, and is aiming to build a quantum computer based upon a superconducting circuit approach to forming qubits. The intention […]

Ionix – Parkwalk closes follow-on investment

By |September 5th, 2017|

We are pleased to announce that the Parkwalk Opportunities EIS Fund has participated in a follow-on financing round into Ionix Advanced Technologies, a Leeds University Spin-out that has developed extreme temperature piezo technology for use in the protection of high value industrial assets. Parkwalk invested alongside existing investor IP Group plc.

The market for piezo technologies […]

Inkpath – University of Oxford Innovation Fund III investment

By |September 4th, 2017|

We are delighted to announce that the University of Oxford Enterprise Fund III has completed its penultimate investment in Inkpath, a data-driven software platform aiming to be the “Fitbit for your career.”

Inkpath is the first comprehensive, data-driven software platform to help its users plan and track their career development in a smart format, with user […]

Mind Foundry – Parkwalk closes follow-on investment

By |September 4th, 2017|

We are delighted to announce that the Parkwalk Opportunities Fund has completed a follow-on investment in Mind Foundry, an Oxford Spin-out company with technology that uses advanced machine learning algorithms to help organisations solve problems by unlocking insights hidden deep within their big data.

Mind Foundry is the result of collaboration between two prominent members […]

9 August 2017

Inductosense – University of Bristol Enterprise Fund II investment

By |August 9th, 2017|

We are delighted to announce that the University of Bristol Enterprise Fund II, managed by Parkwalk, has invested in Inductosense.

Inductosense specialises in the development of compact, wireless sensors for fast, repeatable detection of cracks, corrosion or defects in structures or products.

The company’s aim is to become the leading provider of permanently installed non-destructive testing (NDT) […]

17 July 2017

Parkwalk H1 2017 update

By |July 17th, 2017|

It has been a busy first half of the year at Parkwalk. Our proprietary access to deal-flow has enabled us to deploy £46.5m in the last 12 months. Deal-flow has been enhanced by our tie-up with IP Group plc, who recently raised a further £200m to co-invest in the university spin-out sector.

The combined group […]